Suprathreshold levodopa doses, dyskinesias, and disability in advanced Parkinson's disease.
M W
MW
Horstink
P
P
Praamstra
D000978:Antiparkinson Agents / Q000627:therapeutic use*; D006233:Persons with Disabilities; D004305:Dose-Response Relationship, Drug; D004409:Dyskinesia, Drug-Induced / Q000209:etiology*; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*; D012189:Retrospective Studies
D000978:Antiparkinson Agents; D007980:Levodopa